Clinical trial · Observational
Study in Patients With Solid Tumor Regarding Access to Dermo-cosmetics and Aesthetic Solutions
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
Cancer treatments can trigger cutaneous side-effects, as well as nail and hair toxicities. When related to drug treatment, this iatrogeny depends on the type of drug, its dosage and individual susceptibility. Although these dermatological adverse events are rarely serious, they can significantly alter patients' quality of life, and may even necessitate the introduction of curative treatment. The impact of these side effects can be mitigated by the use of dermo-cosmetic products and aesthetic solutions. However, most of this supportive care is not reimbursed by the health insurance system, representing a source of inequalities in access to healthcare for cancer patients.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Neoplasms | Neoplasm | ONTOLOGY_EXACT | 0.90 |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Questionnaires | Other | — | UNRESOLVED |
Design
Arms and outcomes
Arms (7)
- label
- Patients with Digestive System Cancer
- interventionNames
- Other: Questionnaires
- label
- Patients with Head and Neck Cancer
- interventionNames
- Other: Questionnaires
- label
- Patients with Breast Cancer
- interventionNames
- Other: Questionnaires
- label
- Patients with Nervous System Tumors
- interventionNames
- Other: Questionnaires
- label
- Patients with Urological Cancer
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
Show eligibility criteria text
Inclusion Criteria: * Age \> 18 years * Patients with solid tumors (eligible localization include: digestive system, Head and Neck, Breast, Brain, Lung Tumors, Urological and Gynecologic cancers) * Patients able to read and understand French * Patients that has expressed their consent and with signed consent form Exclusion Criteria: * Minor or patients placed under guardianship or supervision * Patients unable to read French * Patients placed under judicial protection
References
Publications (0)
Data not yet available